CLINICAL_TRIALS
trial_result
· 2019-09-06
Clinical Trial Update: A Study to Compare the Relative Bioavailability of Two Different Formulations of GSK3640254 [Phase 1]
Summary
A Phase 1 study comparing the relative bioavailability of two formulations of GSK3640254 in HIV infections has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: ViiV Healthcare | Conditions: HIV Infections | Phase 1 | Status: COMPLETED | Results posted: 2019-09-06